Home > Health responses to new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2016) Health responses to new psychoactive substances. Luxembourg: Publications Office of the European Union. 30 p.

[img]
Preview
PDF
3MB

While prevalence levels of NPS use remain low in the general European population, there are important concerns with more problematic forms of use and harms. This short report provides an overview of the current situation in terms of NPS use and harms across Europe and reviews the available health- and drug-related interventions in that area.

Table of contents
• Executive summary
• Introduction
• School and family settings
• Nightlife settings
• Sexual health settings
• Emergency and clinical services
• Specialised treatment settings
• Low-threshold settings
• Prisons and custodial settings
• Internet and digital devices as platforms for the delivery of health responses and interventions
• Conclusion
• Consultation participants
• Project examples


Item Type:Evidence resource
Publication Type:Report
Drug Type:New psychoactive substance
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:June 2016
Pages:30 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB 5384 (Available), HRB 5385 (Available)
Subjects:B Substances > New (novel) psychoactive substances
G Health and disease > State of health
J Health care, prevention and rehabilitation > Health care delivery
VA Geographic area > Europe

Repository Staff Only: item control page